Earnings Report

Aetna Inc. is reporting a first-quarter loss of $381 million, after reporting a profit in the same period a year earlier.

Aetna Inc. is reporting a first-quarter loss of $381 million, after reporting a profit in the same period a year earlier.

Merck & Co. is reporting first-quarter earnings of $1.55 billion.

Merck & Co. is reporting first-quarter earnings of $1.55 billion.

Mortgage giant Freddie Mac is reporting net income of $2.2 billion for the first quarter, reversing a loss in the same period of 2016.

ConocoPhillips (COP) on Tuesday reported first-quarter net income of $777 million, after reporting a loss in the same period a year earlier.

MasterCard Inc, the world's second-largest payments network, reported higher-than-expected quarterly profit and revenue as people spent more using credit and debit cards.

Xylem Inc. on Tuesday reported first-quarter earnings of $56 million.

CVS Health Corporation is reporting first-quarter net income of $952 million.

CVS Health Corporation is reporting first-quarter net income of $952 million.

Charter Communications Inc. (CHTR) on Tuesday reported first-quarter net income of $155 million, after reporting a loss in the same period a year earlier.

MasterCard Inc. (MA) on Tuesday reported first-quarter profit of $1.08 billion.

Altria Group is reporting first-quarter net income of $1.4 billion.

Merck & Co reported a better-than-expected quarterly profit, helped by higher gross margins, and the drugmaker also raised its revenue and profit forecasts for 2017.

Aetna reported an adjusted quarterly profit on Tuesday that blew past estimates, helped primarily by strength in its commercial unit.

Drugstore chain and pharmacy benefits manager CVS Health reported a higher-than-expected quarterly profit, helped by demand for high-margin specialty pharmacy services.

Hilton's first-quarter performance topped analyst estimates thanks to solid occupancy rates.

Archer Daniels Midland Co. (ADM) on Tuesday reported first-quarter earnings of $339 million.

Pfizer, the largest U.S. drugmaker, reported a bigger-than-expected quarterly profit, helped by higher sales of breast cancer drug Ibrance and pain relief drug Lyrica.

Pfizer Inc. is reporting first-quarter net income of $3.12 billion.